A new wave of cosmetic surgery is emerging as a consequence of the widespread use of weight-loss drugs like Ozempic, Wegovy, and Mounjaro. Patients who have achieved significant weight loss are now seeking surgical interventions to address the physical changes, particularly the deflation and sagging of skin.
Plastic surgeons report a surge in requests for breast augmentation, tummy tucks, and facial procedures. "We're living through the second wave of the GLP-1 revolution," said Adrian Richards, a consultant plastic surgeon. "The first was about losing weight. Now, for those who’ve lost it, it’s about adapting to the new body they are left with."
The phenomenon has led to the recognition of "Ozempic body" as a distinct category in aesthetic medicine. One nurse noted that approximately 40% of individuals seeking cosmetic procedures are doing so to address the impact of these weight-loss jabs. The effectiveness of skin in adapting to rapid fat loss varies based on factors such as genetics and age. Younger individuals or those with thicker, darker skin tones tend to experience better skin elasticity and recovery.
However, older patients or those with thinner, fairer skin may find that the loss of volume permanently affects their skin's underlying support structure, resulting in loose, deflated tissue that exercise cannot correct. This is particularly noticeable in the breasts, which are composed partly of fatty tissue and can shrink significantly with weight loss. A common complaint is the loss of volume in the upper part of the breast, leading to a flattened or "ski slope" appearance, with the remaining tissue accumulating at the bottom.
Reshaping these breasts presents a more complex surgical challenge than standard breast augmentation. Stretched and thin skin in the chest and arm areas reduces the skin and tissue's ability to maintain a desirable breast shape, requiring a highly skilled surgeon. Patients are advised to consult a surgeon listed on the GMC Specialist Register.
Interestingly, the trend in breast augmentation is shifting away from overly large implants towards more subtle enhancements. Women are increasingly opting for smaller, lower-profile implants, often referred to as "ballerina boobs," which aim for a pert yet natural look. This contrasts with historical trends where larger implants were more common. Many patients also prefer smaller implants to keep their procedures discreet, mirroring the secrecy some maintain about their GLP-1 usage.
Advancements in surgical techniques are also changing the landscape of breast surgery. Modern methods allow for outpatient procedures, with many patients going home the same day. Innovative techniques include injectable breast augmentations with no visible scarring and fat transfer procedures to enhance breast volume or soften implant edges.
However, GLP-1 medications introduce specific considerations for surgery. They can affect how general anesthetics are administered due to their impact on gastric emptying. Surgeons may advise patients to pause their medication before surgery. Furthermore, stabilizing weight for at least six months prior to an operation is recommended to ensure the longevity and success of the results. Significant weight fluctuations after surgery can compromise the outcome, potentially making implant edges visible or thinning the surrounding tissue.
As daily weight-loss pills become more accessible, the impact of GLP-1s on body composition is expected to continue, making surgical adjustments for the resulting physical changes a consistent feature of the cosmetic surgery industry.